IL6 and graft versus host disease: Most previous clinical and experimental studies of IL-6 in allotransplant recipients have investigated the effects of IL-6 on immune cells early during GVHD; the same is true for studies in animal models, except for one previous animal study of sclerodermous chronic GVHD and for some biomarker studies [1].